To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
1. Provide real world data on patient characteristics
Timeframe: Average of 3 years through study completion
2. Provide real world data on disease management
Timeframe: Average of 3 years through study completion
3. Provide real world data on healthcare utilization
Timeframe: Average of 3 years through study completion
4. Provide real world data on quality of care indicators
Timeframe: Average of 3 years through study completion
Provide real world data on cardiovascular outcomes in patients with type 2 diabetes; Chronic Kidney Disease and Heart Failure
Timeframe: Average of 3 years through study completion
6. Provide real world data on renal outcomes and other microvascular complications in patients with type 2 diabetes and Heart Failure
Timeframe: Average of 3 years through study completion
AstraZeneca Clinical Study Information Center